KODK · Eastman Kodak Company

The thesis

Eastman Kodak's turnaround toward advanced materials is still unproven at the level of battery and pharmaceutical revenue, and the third-quarter report decides whether the second quarter was a one-off. That report must repeat the second quarter's $105 million Advanced Materials & Chemicals (AM&C) revenue and 26% consolidated gross margin.

Kodak announced its third-quarter earnings call on 27 October 2026. Kodak's prior notices ran about a week ahead of the call (28 July 2026 for the 4 August 2026 call), which points to a report near 3 November 2026; that date is an estimate.

The shares closed at $9.45 on 27 October 2026 (split- and dividend-adjusted daily closes), up from $8.78 on 14 October 2026 and 34.9% below the 52-week high of $14.51. The 14-day relative strength index (RSI) was 42.6, against 31.8 on 14 October 2026. The three-month price change was 12.9%. No company filing or news item in the period explains the rebound.

The narrative is maturing: the operating case still rests on the 4 August 2026 results, and the only fresh item since then is the 1 October 2026 Ateios Systems release naming Kodak as a toll coating partner without a revenue figure.

Bullish and bearish views on Eastman Kodak Company

The bull case on Eastman Kodak Company (KODK), in brief: Segment growth came with higher earnings. The bear case: The $9.45 close on 27 October 2026 is below the 18 September 2026 and 1 October 2026 closes.

Bull case

• Segment growth came with higher earnings. Kodak's 4 August 2026 release reported AM&C operational EBITDA (earnings before interest, taxes, depreciation and amortization) of $22 million versus $8 million a year earlier. Segment revenue rose from $75 million to $105 million.
• Consolidated margin widened. Q2 gross profit was $82 million versus $51 million, and gross margin was 26% versus 19%, per the 4 August 2026 release. Consolidated revenue was $311 million versus $263 million, and Benzinga's corrected Q2 earnings per share was $0.13 versus $(0.36) a year earlier.
• A named battery partner exists. Ateios's 1 October 2026 release said its 50-megawatt-hour electrode coating line in Indiana is operating and named Kodak as toll coating partner for its RaiCore electrodes. Ateios gave capacity figures, not Kodak revenue.
• The shares have recovered part of the October drop. The close of $9.45 on 27 October 2026 compares with $8.78 on 14 October 2026. The 14-day RSI of 42.6 is no longer near the 30 level that screens call oversold.

Bear case

• The $9.45 close on 27 October 2026 is below the 18 September 2026 and 1 October 2026 closes.
• Product mix is still undisclosed. Kodak groups motion picture film, pharmaceutical reagents and battery coating inside AM&C with no separate revenue, per its 4 August 2026 disclosures. The segment's growth cannot yet be assigned to battery work.
• Silver costs press on margin. Management's 4 August 2026 commentary described silver prices as more than double year-end levels and tied the inventory build mainly to silver. A gross margin below 26% with silver cited would break the margin argument.
• Cash fell despite higher earnings. Cash was $290 million on 30 June 2026 versus $337 million on 31 December 2025, after $101 million of term-loan repayments and a $37 million inventory increase, per the Q2 filing.
• Share supply is registered. The 1 July 2026 prospectus supplement (424B7) covered resale of up to about 39.46 million shares and the 8 July 2026 supplement (424B3) a further 4.43 million. Kodak also has a $100 million at-the-market stock-sale program filed in November 2025.

Price setup

The shares closed at $9.45 on 27 October 2026, within the $8.78 to $9.85 range of closes set between 1 October 2026 and 14 October 2026. The 52-week high is $14.51, 34.9% above the latest close. The 14 October 2026 close of $8.78 is the near-term floor in that range, and the $8.00 level in the invalidation condition sits below it.

Crowding evidence is light on the buying side. No major-firm ratings or price targets are listed on aggregators, no insider transactions appear in filings since the July resale registrations, and the 27 October 2026 call announcement means the earnings report is days away. The registered resale shares and the at-the-market program are the observable sources of supply.

Catalysts, next 30 days

• Within the Q3 filing: cash, inventory and share issuance. The 10-Q shows whether cash stabilised after the $101 million of term-loan repayments and whether any at-the-market sales occurred.

Elapsed catalysts

• ~3 November 2026 (est.): Q3 2026 results and call. Kodak announced the call on 27 October 2026; the report date is an estimate based on its notice-to-call spacing and Earnings Whispers. It tests AM&C revenue at $105 million or more and gross margin at 26% or more. (passed 3d ago)

What would change the view

The case breaks if Q3 AM&C revenue falls below the second quarter's $105 million, or if consolidated gross margin falls below 26% with management citing silver costs and no pricing offset. A report that attributes the AM&C increase mainly to film, with no separate battery or pharmaceutical figures, would leave the turnaround claim unsupported.

The case strengthens if Kodak breaks out battery or pharmaceutical revenue, or quantifies the Ateios toll coating work. A new prospectus supplement or reported at-the-market sales would add supply.

On price, a daily close below $8.00, under the 14 October 2026 close of $8.78, ends the thesis.

What it trades with

Kodak's margin is sensitive to silver prices, which management cited on 4 August 2026 as more than double year-end levels. AM&C's battery line depends on customers such as Ateios scaling electrode production. The legacy Print business follows commercial print and packaging demand, and Kodak's TOKYO PACK 2026 exhibit ended 16 October 2026 without a stated revenue effect.